ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2015 American Transplant Congress

    Spironolactone Prevents Calcineurin Inhibitors Toxicity in Renal Allografts. Preliminary Report

    J. Martinez, I. Vargas, B. Chagolla, A. Ramirez, J. Bermudez.

    Nephrology, Hospital General "Dr Miguel Silva", Morelia, Michoacan, Mexico.

    Introduction: Calcineurin inhibitors (CI) introduction was a transcendental event in the transplant medicine history. Actually, CI are considered the cornerstone in the immunosuppression treatment because…
  • 2015 American Transplant Congress

    Pre-Liver Transplant Urinary Proteome Analysis Does Not Predict Development of Chronic Kidney Disease After Transplantation

    D. Milongo,1,3 J. Bascands,2,3,4 L. Esposito,1,3 L. Lavayssière,1,3 A. Del Bello,1,3 L. Rostaing,1,3,5 J. Schanstra,2,3,4 N. Kamar.1,3,5

    1Department of Nephrology and Organ Transplantation, CHU Rangueil, Toulouse, France; 2Institut National de la Santé et de la Recherche Médicale (INSERM), U1048, Institut of Cardiovascular and Metabolic Disease, Toulouse, France; 3Université Toulouse III Paul-Sabatier, Toulouse, France; 4Plateau de Protéomique des Liquides Biologiques, Institut of Cardiovascular and Metabolic Disease, Toulouse, France; 5INSERM U1043, IFR–BMT, Toulouse, France.

    Background and aims: Chronic kidney disease (CKD) is a common complication after liver transplantation. Kidney biopsies cannot be easily performed before liver transplantation to predict…
  • 2015 American Transplant Congress

    Long-Term Impact of Live Liver Donation: A Self Report of the Donation Experience

    D. LaPointe Rudow,1 S. DeLair,2 S. Florman,1 J. Guarrera,3 M. Kinkhabwala,4 M. Orloff,5 Y. Wu,6 L. Teperman.7

    1Mount Sinai Medical Center, New York, NY; 2NYCLT, Albany, NY; 3New York Presbyterian Hospital, New York, NY; 4Montefiore Medical Center, Bronx, NY; 5University of Rochester Medical Center, Rochester, NY; 6Westchester Medical Center, Valhala, NY; 7New York University Hospitals Center, New York, NY.

    Introduction: Recipient outcomes of LDLT are well reported, however outcomes for adult to adult living liver donors (LD) are based on short term data. Much…
  • 2015 American Transplant Congress

    Blood Pressure Evaluation by Three Different Modalities in Living Kidney Donors

    Z. Zaky, G. Thomas, S. Gebreselassie, E. Poggio.

    Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH.

    Screening for hypertension (HTN) is an important element of the living kidney donor (LKD) evaluation process. Since there are no general consensus about the blood…
  • 2015 American Transplant Congress

    Predictive Value of Postoperative CRP and Procalctonin in Kidney Donors Experiencing Surgical Complications

    Z. Ahmed, R. Tamburrini, J. Wright, N. Kessaris, N. Mamode.

    Renal and Pancreatic Transplantation, Guy's Hospital, London, United Kingdom.

    Introduction: Patients undergoing donor nephrectomy are fit and well individuals. Despite this, 1 in 5 will suffer a perioperative complication causing significant morbidity. Recent published…
  • 2015 American Transplant Congress

    The Impact of Alemtuzumab and Basiliximab Induction On Patient and Graft Survival in Single Lung Transplant Recipients

    Y. Furuya,1 S. Jayarajan,2 S. Taghavi,2 V. Ambur,2 F. Cordova,3 N. Patel,3 Y. Toyoda.4

    1Internal Medicine, Temple University Hospital, Philadelphia, PA; 2Surgery, Temple University Hospital, Philadelphia, PA; 3Pulmonary & Critical Care, Temple University Hospital, Philadelphia, PA; 4Cardiothoracic Surgery, Temple University Hospital, Philadelphia, PA.

    PurposeTo evaluate the impact of alemtuzumab, basiliximab and no induction therapy on patient survival and chronic rejection.Methods3242 adult single lung transplantation from 2006 to 2013…
  • 2015 American Transplant Congress

    Obesity: A Major Risk Factor for Wound and Parietal Complications in Renal Transplantation

    H. Andrade, W. Nahas, R. Kato, K. Yamaçake, H. Kanashiro, I. Antonopoulos, A. Bull, R. Falci, A. Piovesan.

    Division of Urology, Renal Transplantation Unit, University of Sao Paulo, Sao Paulo, Brazil.

    Purpose: The increase of obesity among patients with end-stage renal disease poses a major challenge for urologists and nephrologists. Many centers set an upper limit…
  • 2015 American Transplant Congress

    Acoustic Radiation Force Impulse Measurement in Renal Transplantation

    J. Lee,1 J. Lee,1 A.-l. Lee,2 B. Ma,3 Y. Oh,4 K. Huh,1 M. Kim,1 S. Kim,1 Y. Kim,1 D. Joo.1

    1Department of Transplantation Surgery, Yonsei University Health System, Seoul, Republic of Korea; 2Department of Surgery, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea; 3Biostatistics Collaboration Unit, Yonsei University College of Medicine, Seoul, Republic of Korea; 4Department of Radiology, Yonsei University Health System, Seoul, Republic of Korea.

    BackgroundAllograft biopsy is the definitive diagnostic methods for evaluation of renal dysfunction, but there is always the risk of complications. Efforts to develop a notable…
  • 2015 American Transplant Congress

    Potential Urine Protein Biomarkers for Kidney Transplantation Dysfunction Through Quantitative Proteomics

    T. Sigdel,1 N. Salomonis,2 C. Nicora,3 J. He,3 W.-J. Qian,3 D. Camp,3 M. Sarwal.1

    1UCSF, San Francisco, CA; 2Cincinnati Children's Hospital Medical Center, Cincinnati, OH; 3Pacific Northwest National Laboratory, Richland, WA.

    Introduction: Inability to effectively monitor transplant injuries leads to immune and non-immune mediated graft dysfunction. A non-invasive tool to monitor such injuries is an unmet…
  • 2015 American Transplant Congress

    ABCB1 Haplotypes, Sex, Calcineurin Inhibitors and Lipid Profiles Post-Renal Transplant

    C. Meaney,1,2 R. Venuto,3 D. Brazeau,4 J. Consiglio,5 L. Cooper,1 G. Wilding,5 K. Tornatore.1,2,3

    1NYS Center of Excellence in Bioinformatics and Life Sciences, Buffalo, NY; 2School of Pharmacy, Buffalo, NY; 3Medicine, School of Medicine, Buffalo, NY; 4University of New England College of Pharmacy, Portland, ME; 5Biostatistics, School of Public Health, University at Buffalo, Buffalo, NY.

    Purpose: Hyperlipidemia is common in renal transplant recipients (RTR) during calcineurin inhibitor (CNI) immunosuppression. P-glycoprotein (P-gp) is an efflux transporter encoded by ABCB1 that modulates…
  • « Previous Page
  • 1
  • …
  • 111
  • 112
  • 113
  • 114
  • 115
  • …
  • 170
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences